A-118 Psychedelic Interventions for Neuropsychological Conditions
Archives of Clinical Neuropsychology August 17, 2022 Brian Peacock 3 citations
Psychedelic-assisted therapies, including ketamine, MDMA, and psilocybin, show promise for treating depression, anxiety, PTSD, and substance use disorders. This systematic review identified new potential applications for these therapies in neuropsychological conditions such as traumatic brain injury, stroke, autism spectrum disorder, and ADHD, while also noting contraindications when psychological disorders co-occur with neuropsychological conditions. The findings are synthesized to provide actionable clinical recommendations for practitioners.